Boston Scientific

Endostart Appoints Christopher Rowland Chairman of the Company’s Board of Directors.

Retrieved on: 
Friday, July 15, 2022
Professional Services, Health, Medical Devices, Hospitals, Start-Up, Other Health, Biotechnology, Leadership, Global, CEO, Patient, Colonoscopy, Radiology, Technology, Urology, Teleflex, CE, Marketing, Gastroenterology, Board of directors, Multimedia, Board, Physician, Cardiology, US Foods, Growth, USD, Boston Scientific, Hemostasis, FDA, Medical device, Management

The growth of Italian medical device start-up Endostart continues with the appointment of Christopher Rowland, a global expert in the medical device industry, to Chairman of the companys Board of Directors.

Key Points: 
  • The growth of Italian medical device start-up Endostart continues with the appointment of Christopher Rowland, a global expert in the medical device industry, to Chairman of the companys Board of Directors.
  • View the full release here: https://www.businesswire.com/news/home/20220714005706/en/
    Endostart is proud to announce the appointment of Chris Rowland as Chairman of the companys Board of Directors.
  • With his long history of leadership and his expertise in the digestive endoscopy industry, Chris is the ideal Chairman of the Board for Endostart, said Alessandro Tozzi, CEO and founder of Endostart.
  • I believe Endostart is poised for significant growth reflecting demand for its innovative products to enhance endoscopic performance, said Mr. Rowland.

Armored Things Appoints Richard Scannell as New CEO, Board Member

Retrieved on: 
Thursday, July 14, 2022
University, General manager, Thought, Login VSI, Maintenance, School, CEO, Wi-Fi, GLOBE, Workplace, Boston Scientific, AI, Sport, Board, Growth, Intelligence, Software, Management, Asset management

BOSTON, July 14, 2022 (GLOBE NEWSWIRE) -- Armored Things , a leading provider of AI software for smart space planning, today announced the appointment of Richard Scannell as CEO and Board Member, as co-founder Julie Roberts moves into the role of Chief Strategy Officer.

Key Points: 
  • BOSTON, July 14, 2022 (GLOBE NEWSWIRE) -- Armored Things , a leading provider of AI software for smart space planning, today announced the appointment of Richard Scannell as CEO and Board Member, as co-founder Julie Roberts moves into the role of Chief Strategy Officer.
  • Scannell will manage Armored Things' overall operations, including business synergies, profitability, organizational structure, and company growth.
  • Scannell brings a wealth of experience to Armored Things, having successfully managed companies through every different stage of their growth.
  • Armored Things leverages existing data sources such as Wi-Fi, cameras, and sensors to provide anonymous, real-time and predictive analytics.

Sonasoft Appoints New Senior Vice President of Product

Retrieved on: 
Wednesday, July 13, 2022
Rajiv, Senior, Wells Fargo, Company, COO, FIS, SAN, GLOBE, Boston Scientific, AI, CA, OTCQB, Management, Audit, Product, Silicon

SAN JOSE, CA, July 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire Sonasoft Corp. (OTCQB: SSFT) is delighted to announce that Rajiv Kaushik has joined the company as Senior Vice President of Product.

Key Points: 
  • SAN JOSE, CA, July 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire Sonasoft Corp. (OTCQB: SSFT) is delighted to announce that Rajiv Kaushik has joined the company as Senior Vice President of Product.
  • Rajiv brings a huge amount of experience to Sonasoft having worked at major companies including Boston Scientific, FIS, and Wells Fargo.
  • His broad product experience and background with major corporations will be extremely valuable for Sonasoft.
  • Caroline Zabarowksi, Sonasofts Chief Data Officer, said, Rajiv will help provide deep product experience to Sonasoft.

Kevin Richardson appointed as CEO, Telix Americas

Retrieved on: 
Sunday, July 10, 2022
FDA, LinkedIn, CEO, Moses Austin, Nuclear medicine, TLX, ASX, Marketing, Growth, Degenerative disease, Liver cancer, Company, Boston Scientific, Australian Securities Exchange, MBA, Food, University, MTR, General manager, Head, St. Jude Medical, TGA, Radiopharmaceutical, Regulation of tobacco by the U.S. Food and Drug Administration, Gallium, Management, Pharmaceutical industry, Telix

MELBOURNEand INDIANAPOLIS, July 10, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company)is pleased to announce that Kevin Richardson, a senior global executive with a career focus on sales, marketing and business operations in the oncology and radiopharmaceutical markets, will commence in the role of CEO, Telix Americas, on 11 July 2022.

Key Points: 
  • MELBOURNEand INDIANAPOLIS, July 10, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company)is pleased to announce that Kevin Richardson, a senior global executive with a career focus on sales, marketing and business operations in the oncology and radiopharmaceutical markets, will commence in the role of CEO, Telix Americas, on 11 July 2022.
  • During his tenure, firstly as Head of Sales, and then subsequently in the roles of General Manager and CEO Americas, Kevin oversaw a five-fold increase in sales for the U.S. region.
  • I have confidence that Kevin brings the leadership skills and track record that will drive our growth in the region."
  • Kevin Richardson added, "I'm very excited to take on the role of CEO for Telix Americas.

Worldwide Bioprosthetic Heart Valves Industry to 2028 - by Type, End-user and Region - ResearchAndMarkets.com

Retrieved on: 
Friday, July 8, 2022
Health, Cardiology, American College of Cardiology, Aortic valve, Trifecta, Patient, Lists of countries and territories, Research, CVD, Adoption, International Medical Center, Boston Scientific, Femoral artery, Growth, St. Jude Medical, Edwards Lifesciences, Prevalence, Abbott Laboratories, CAGR, MHLW, Degenerative disease, Catheter, Incidence, Government, Aeson, Hospital, Medical device, Medical imaging, Marketing, Health

The global bioprosthetic heart valves market is anticipated to grow at a substantial CAGR of 11.4% during the forecast period.

Key Points: 
  • The global bioprosthetic heart valves market is anticipated to grow at a substantial CAGR of 11.4% during the forecast period.
  • The global bioprosthetic heart valves market is segmented based on the type, and end-user.
  • Analysis of regional regulations and other government policies impacting the global bioprosthetic heart valves market.
  • Insights about market determinants that are stimulating the global bioprosthetic heart valves market.

Outlook on the Fractional Flow Reserve Global Market to 2027 - AI & ML Revolutionizing FFR-CT - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 7, 2022
Health, Cardiology, CAD, First Nations in Ontario, Patient, Ageing, IHD, FFR, Adult, Probability, United Nations, Adoption, Death, Population, Urbanization, Boston Scientific, Obesity, Cardiovascular disease, Philips, Gross domestic product, Metabolic syndrome, Chest pain, Fractional flow reserve, Degenerative disease, Machine learning, GDP, Incidence, AI, Artificial intelligence, Coronary artery disease, Oil, Pharmaceutical industry, Medical imaging, Medical device, Developing country

The "Fractional Flow Reserve Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Fractional Flow Reserve Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The fractional flow reserve (FFR) is a gold standard for assessing coronary artery disease during invasive coronary angiography.
  • The usage of non-invasive fractional flow reserve systems is increasing due to innovative methods in healthcare systems.
  • This increasing target population globally will drive the global fractional flow reserve market growth.

Imperative Appoints Industry Veteran as New Chief Executive Officer to Drive Scaling of Company

Retrieved on: 
Thursday, July 7, 2022
Software, Networks, Internet, Professional Services, Data Management, Technology, Artificial Intelligence, Audio, Video, Human Resources, Other Technology, Consulting, Telecommunications, Acquisition, Customer success, GSK, Mentorship, Shiftboard, Growth, Â, Boston Scientific, Trust, Software as a service, Chronos, Marketing, Technology, B2B, Organization, WebMD, AI, Microsoft, Management, Video game, Imperative, Hasbro, Zillow, Accolade

Imperative , the enterprise peer coaching platform, announced today that Steve OBrian has joined the company as the Chief Executive Officer.

Key Points: 
  • Imperative , the enterprise peer coaching platform, announced today that Steve OBrian has joined the company as the Chief Executive Officer.
  • Recently, the company announced the addition of J.R. Jesson as its Chief Technology Officer.
  • OBrian is a B2B SaaS startup veteran with multiple successful exits and over 20 years of executive experience.
  • Steve brings critical growth experience and scaling acumen that will help Imperative take full advantage of the opportunity.

MedCrypt Welcomes Ken Hoyme to Advisory Board

Retrieved on: 
Wednesday, July 6, 2022
Department, Ethics, AAMI, Fellow, Degree, CEO, Arrhythmia, Honeywell, Y Combinator, University, Reflection, Device, 777, Corporation, Industry, Electricity, Program in Liberal Medical Education, Health, Management control system, SAN, DHS, Boeing, Privacy, Bachelor, Technology, Eniac Ventures, Organization, Software, Risk management, Virginia Tech Corporate Research Center, Solution, Board, Leadership, Safety, Center, United States Department of Homeland Security, Medical device, Lucile Eleanor St. Hoyme, Boston Scientific

SAN DIEGO, July 6, 2022 /PRNewswire/ -- MedCrypt Inc., the leading provider of proactive security solutions for the healthcare space, today announced the addition of Ken Hoyme to its advisory board. Ken brings 40 years of experience in designing regulated, safety-critical secure systems as well as his knowledge of medical device security and regulation. In this role, Ken will advise MedCrypt's strategy and support the company on its path of continual growth as a leading provider of medical device cybersecurity solutions.

Key Points: 
  • Hoyme brings experience from Boston Scientific, Adventium Labs, and Honeywell to the proactive medical device cybersecurity provider
    SAN DIEGO, July 6, 2022 /PRNewswire/ -- MedCrypt Inc. , the leading provider of proactive security solutions for the healthcare space, today announced the addition of Ken Hoyme to its advisory board.
  • Ken brings 40 years of experience in designing regulated, safety-critical secure systems as well as his knowledge of medical device security and regulation.
  • "Having Ken Hoyme join our advisory board shows MedCrypt's continued commitment to providing safety-focused cybersecurity solutions to medical device manufacturers.
  • Ken joins as an advisor alongside Michael McNeil, who was added to MedCrypt's Board of Directors in 2020.

DGAP-News: SphingoTec appoints Jörg Menten as CEO to accelerate commercialization and global growth

Retrieved on: 
Thursday, June 30, 2022
Nexus, Incident management team, Diagnosis, Acquisition, Patient, Sepsis, CEO, N-terminal prohormone of brain natriuretic peptide, Precision medicine, Research, Adoption, PCT, Interventional radiology, Roche Diagnostics, Biomarker, DPP3, Growth, Liver cancer, Boston Scientific, CSO, CCO, CFO, MBA, Hennigsdorf, IVD, TSH, University, NYSE, University Hospital Mannheim, Point of care, Advisory board, CA, Advisory, The Advisory Board Company, Leadership, POC, IPO, Vanguard, Senior management, Management, Medical device, Critical care, Troponin

SphingoTec appoints Jrg Menten as Chief Executive Officer (CEO) as from July 1, 2022 to drive the commercialization and scale its diagnostic business.

Key Points: 
  • SphingoTec appoints Jrg Menten as Chief Executive Officer (CEO) as from July 1, 2022 to drive the commercialization and scale its diagnostic business.
  • Hennigsdorf/Berlin, Germany, June 30, 2021 Diagnostics company SphingoTec GmbH (SphingoTec) today announced that Jrg Menten was appointed CEO of SphingoTec effective of July 1, 2022.
  • Jrg Menten is a highly skilled senior executive with a long-standing track record of leadership positions in the global healthcare industry.
  • On behalf of the Advisory Board I welcome Jrg Menten in his new capacity as CEO of SphingoTec.

Boston Scientific Announces Conference Call Discussing Second Quarter 2022 Results

Retrieved on: 
Wednesday, June 29, 2022
EDT, Boston, Science, Patient, BSX, Life, Webcast, Boston Scientific, Twitter, News, NYSE, Health, Management, Facebook

MARLBOROUGH, Mass., June 29, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ending June 30, 2022 on Wednesday, July 27, 2022 at 8:00 a.m. EDT.

Key Points: 
  • MARLBOROUGH, Mass., June 29, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ending June 30, 2022 on Wednesday, July 27, 2022 at 8:00 a.m. EDT.
  • The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer.
  • The company will issue a news release announcing financial results for the second quarter on July 27 prior to the conference call.
  • Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.